Tramadol News and Research

RSS
Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Drug release of tramadol hydrochloride increases from 1.9 to 7.5 hours by adding Novozymes Biopharma’s Hyasis®

Drug release of tramadol hydrochloride increases from 1.9 to 7.5 hours by adding Novozymes Biopharma’s Hyasis®

Eisai submits BELVIQ NDS with Health Canada

Eisai submits BELVIQ NDS with Health Canada

Teva to present abstracts on AZILECT at MDS meeting

Teva to present abstracts on AZILECT at MDS meeting

New challenges to military medicine

New challenges to military medicine

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

Growth in opioid use prompts safety concerns

Growth in opioid use prompts safety concerns

Teva initiates enrollment in AZILECT Phase IV clinical study for PD-MCI

Teva initiates enrollment in AZILECT Phase IV clinical study for PD-MCI

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Study sheds new light on potential habit-forming properties of tramadol

Study sheds new light on potential habit-forming properties of tramadol

Chronic nerve pain: an interview with Professor Sally Lawson

Chronic nerve pain: an interview with Professor Sally Lawson

Rapid test to identify patients not responding to painkiller tramadol

Rapid test to identify patients not responding to painkiller tramadol

Simple blood test can quickly identify 'poor metabolisers'

Simple blood test can quickly identify 'poor metabolisers'

FDA approves Cipher’s Absorica to treat severe recalcitrant nodular acne

FDA approves Cipher’s Absorica to treat severe recalcitrant nodular acne

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

Ampio submits pre-IND package on Zertane to FDA

Ampio submits pre-IND package on Zertane to FDA

ASN participates in ABIM Foundation's Choosing Wisely campaign

ASN participates in ABIM Foundation's Choosing Wisely campaign

Ampio, Australian TGA reach agreement over Zertane submission plan

Ampio, Australian TGA reach agreement over Zertane submission plan

New ACR guidelines recommend use of topical NSAIDs for older patients with knee OA

New ACR guidelines recommend use of topical NSAIDs for older patients with knee OA